Publikationen von Hannelore Ehrenreich

Begemann, M.; Sargin, D.; Rossner, M. J.; Bartels, C.; Theis, F.; Wichert, S. P.; Stender, N.; Fischer, B.; Sperling, S.; Stawicki, S. et al.; Wiedl, A.; Falkai, P.; Nave, K.-A.; Ehrenreich, H.: Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Molecular Medicine 14 (9-10), S. 546 - 552 (2008)

Byts, N.; Samoylenko, A.; Fasshauer, T.; Ivanisevic, M.; Hennighausen, L.; Ehrenreich, H.; Sirén, A.-L.: Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death and Differentiation 15, S. 783 - 792 (2008)

Ehrenreich, H.; Bartels, C.; Sargin, D.; Stawicki, S.; Krampe, H.: Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition. Journal of Renal Nutrition 18 (1), S. 146 - 153 (2008)

Hassouna, I.; Sperling, S.; Kim, E.; Schulz-Schaeffer, W.; Rave-Fränk, M.; Hasselblatt, M.; Jelkmann, W.; Giese, A.; Ehrenreich, H.: Erythropoietin augments survival of glioma cells after radiation and temozolomide. International Journal of Radiation Oncology, Biology, Physics 72 (3), S. 927 - 934 (2008)

Jamain, S.; Radyushkin, K.; Hammerschmidt, K.; Granon, S.; Boretius, S.; Varoqueaux, F.; Ramanantsoa, N.; Gallego, J.; Ronnenberg, A.; Winter, D. et al.; Frahm, J.; Fischer, J.; Bourgeron, T.; Ehrenreich, H.; Brose, N.: Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proceedings of the National Academy of Sciences of the United States of America 105 (5), S. 1710 - 1715 (2008)

Krampe, H.; Bartels, C.; Victorson, D.; Enders, C. K.; Beaumont, J.; Cella, D.; Ehrenreich, H.: The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotrophic Lateral Sclerosis 9, S. 99 - 107 (2008)

Krampe, H.; Stawicki, S.; Ribbe, K.; Wagner, T.; Bartels, C.; Kroener-Herwig, B.; Ehrenreich, H.: Development of an outcome prediction measure for alcoholism therapy by multimodal monitoring of treatment processes. Journal of Psychiatric Research 43, S. 30 - 47 (2008)

Pitzer, C.; Krüger, C.; Plaas, C.; Kirsch, F.; Dittgen, T.; Müller, R.; Laage, R.; Kastner, S.; Suess, S.; Spoelgen, R. et al.; Henriques, A.; Ehrenreich, H.; Schäbitz, W.-R.; Bach, A.; Schneider, A.: Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis. Brain 131, S. 3335 - 3347 (2008)

Samoylenko, A.; Byts, N.; Rajalingam, K.; von Ahsen, N.; Rapp, U. R.; Ehrenreich, H.; Sirén, A.-L.: Thrombopoietin inhibits nerve growth factor-induced neuronal differentiation and ERK signalling. Cellular Signalling 20, S. 154 - 162 (2008)

Ehrenreich, H.; Fischer, B.; Norra, C.; Schellenberger, F.; Stender, N.; Stiefel, M.; Sirén, A.-L.; Paulus, W.; Nave, K.-A.; Gold, R. et al.; Bartels, C.: Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130 (10), S. 2577 - 2588 (2007)

Nave, K.-A.; Sereda, M. W.; Ehrenreich, H.: Mechanisms of Disease: inherited demyelinating neuropathies - from basic to clinical research. Nature Clinical Practice Neurology 3 (8), S. 453 - 464 (2007)

Bartels, C.; Kunert, H.-J.; Stawicki, S.; Kroner-Herwig, B.; Ehrenreich, H.; Krampe, H.: Recovery of hippocampus-related functions in chronic alcoholics during monitored long-term abstinence. Alcohol and Alcoholism 42 (2), S. 92 - 102 (2007)

Ehrenreich, H.; Hinze-Selch, D.; Stawicki, S.; Aust, C.; Knolle-Veentjer, S.; Wilms, S.; Heinz, G.; Erdag, S.; Jahn, H.; Degner, D. et al.; Ritzen, M.; Mohr, A.; Wagner, M.; Schneider, U.; Bohn, M.; Huber, M.; Czernik, A.; Pollmacher, T.; Maier, W.; Sirén, A.-L.; Klosterkötter, J.; Falkai, P.; Rüther, E.; Aldenhoff, J. B.; Krampe, H.: Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Molecular Psychiatry 12 (2), S. 206 - 220 (2007)

Krampe, H.; Stawicki, S.; Hoehe, M. R.; Ehrenreich, H.: Outpatient long-term intensive therapy for alcoholics (OLITA): a successful biopsychosocial approach to the treatment of alcoholism. 4, S. 399 - 412 (2007)

Stawicki, S.; Krampe, H.; Niehaus, S.; Ribbe, K.; Wagner, T.; Bartels, C.; Kröner-Herwig, B.; Ehrenreich, H.: Multimodales Monitoring psychotherapeutischer Prozesse in der Behandlung alkoholkranker Patienten. Suchtmedizin in Forschung und Praxis 9 (1), S. 27 - 47 (2007)

Stawicki, S.; Krampe, H.; Ribbe, K.; Niehaus, S.; Wagner, T.; Ehrenreich, H.: Ambulante Langzeit-Intensivtherapie für Alkoholkranke (ALITA). Der Neurologe und Psychiater 3, S. 27 - 32 (2007)

Weishaupt, J. H.; Bartels, C.; Pölking, E.; Dietrich, J.; Rohde, G.; Poeggeler, B.; Mertens, N.; Sperling, S.; Bohn, M.; Hüther, G. et al.; Schneider, A.; Bach, A.; Sirén, A.-L.; Hardeland, R.; Bähr, M.; Nave, K.-A.; Ehrenreich, H.: Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of Pineal Research 41 (4), S. 313 - 323 (2006)

Byts, N.; Samoylenko, A.; Woldt, H.; Ehrenreich, H.; Sirén, A.-L.: Cell type specific signalling by hematopoietic growth factors in neural cells. Neurochemical Research 31 (10), S. 1219 - 1230 (2006)

Brettschneider, J.; Widl, K.; Ehrenreich, H.; Riepe, M.; Tumani, H.: Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neuroscience Letters 404 (3), S. 347 - 351 (2006)

Krampe, H.; Wagner, T.; Stawicki, S.; Bartels, C.; Aust, C.; Kroener-Herwig, B.; Kuefner, H.; Ehrenreich, H.: Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment. Psychiatric Services 57 (5), S. 708 - 712 (2006)